KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | -66.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -97.8% | 1,000 | -96.0% | 0.00% | – |
| Q1 2022 | $182,000 | -9.9% | 24,729 | -21.6% | 0.00% | – |
| Q4 2021 | $202,000 | +242.4% | 31,543 | +450.9% | 0.00% | – |
| Q2 2021 | $59,000 | -24.4% | 5,726 | -23.2% | 0.00% | – |
| Q1 2021 | $78,000 | -83.6% | 7,456 | -75.8% | 0.00% | -100.0% |
| Q4 2020 | $477,000 | +736.8% | 30,846 | +936.8% | 0.00% | – |
| Q1 2020 | $57,000 | – | 2,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |